• Rare earth element (“REE”) enterprise Ucore Rare Metals Inc. is developing an innovative separation technology for REEs critical to modern computer technologies
• The company is preparing to advance the operational machinery being used to demonstrate Ucore’s proprietary RapidSX(TM) solution side-by-side with conventional separation technology, designing a similar commercial operation that will begin commissioning next year in Louisiana
• China currently dominates the global market for mining, processing, and product creation for REEs, leading to American concerns about vulnerability to price and supply policies controlled by China’s government
• Ucore has received a $4 million award from the U.S. Department of Defense to demonstrate the effectiveness of RapidSX(TM), which includes an additional $10 million for launching the commercial Louisiana operation

Strategic metals supply chain-focused enterprise Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is driving American hemisphere innovation in the rare earth element (“REE”) market as a means of protecting Western inventions and technological applications from becoming too vulnerable to The People’s Republic of China’s control over critical resources.

Ucore Chairman and CEO Pat Ryan addressed the company’s development of its proprietary RapidSX(TM) REE processing solution, its preparations to progress from testing at Ucore’s Ontario demonstration plant to a commercial plant in Louisiana, and its savvy use of government funding incentives to move the process as quickly as possible during Ryan’s appearance at Red Cloud’s Fall Mining Showcase 2023.

“Permanent magnets are the things that drive renewable energy. They drive the wind turbines, they drive the electric vehicles (‘EVs’). Those permanent magnets are made with rare earth elements. But the rare earth elements are actually quite controlled by China,” Ryan told RCTV during a Showcase interview (https://ibn.fm/9qwHc). “So resource-side, they control 60 percent of the resource. Separation, mid-stream, 87 percent of the resource, and downstream 90 percent-plus,” he said.

Amid the transition to generating energy from renewable sources, the process is “going to be controlled by China going forward,” Ryan said. “So Ucore’s looked at it and said, ‘Where will we enter the market?’ The most logical place is in the mid-market, the middle of the market where China’s taking control of that 87 percent — use Westernized tech, develop separation for those critical seeds of technology, as the Japanese call it, and that will … connect the bridge between the resource and the downstream magnet makers.”

During his presentation to attendees at the Fall Mining Showcase, Ryan noted that about 90 million vehicles are made each year, and by the end of the decade a third of them are expected to be EVs despite current concerns about cooling trends in the EV market that Ryan labels simple supply and demand adjustments.

He also noted potential national security concerns in that REEs are used in military applications.

“There’s actually 920 pounds of rare earths in an F-35 fighter. Missile guiding systems work because of rare earth permanent magnets. Those rare earths are controlled by China,” he said (https://ibn.fm/takaX).

Ucore’s strategic response is to build three processing plants — the first being the soon-to-launch facility in Louisiana — that allow a “self-use” approach to processing REEs domestically without having to ship it to China first.

“And let’s joint-venture with a couple of mining operations to be able to, in an in situ way, whether it’s in Australia, western Africa, South America, build a plant that works with the mining companies,” Ryan said.

Building a 5,000-ton solvent extraction plant using the industry’s existing conventional separation process (“SX”) would cost $300 million-plus, he said, whereas building a 5,000-ton RapidSX(TM) plant will take about $55 million using a more slender footprint with less demand for electricity.

“Is (commercializing the RapidSX(TM) process) a leap? No, it’s not a leap, because it’s the same chemistry and that chemistry’s proven. But let’s apply it that much more effectively,” Ryan said.

The company has received a $4 million award from the U.S. Department of Defense to demonstrate the effectiveness of RapidSX(TM) in Canada, and anticipates an additional $10 million in funding to help launch the commercial Louisiana operation, he said. Ucore has also been talking with automotive companies about the possibility of reaching pre-purchase supply agreements as an additional form of investing in the company’s future.

For more information, visit the company’s website at www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

• Longeveron recently released topline results from its Phase 2a trial evaluating Lomecel-B(TM) as a potential treatment for mild AD
• The study met its primary safety endpoint across all four study groups and showed positive and statistically significant results in secondary endpoint involving the Composite Alzheimer’s Disease Score (“CADS”) for Lomecel-B(TM) and components of the CADS
• The positive results are expected to form the basis for further development of Lomecel-B(TM) as a potential treatment for mild AD

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions for which there is an unmet medical need, announced on October 5 its topline results from its Phase 2a trial, called the CLEAR MIND trial, investigating Lomecel-B(TM) for the treatment of mild Alzheimer’s disease (“AD”) (https://ibn.fm/b6G9m). The announcement was featured in a recent NetworkNewsAudio (“NNA”) broadcast, which is part of an overall goal to deliver additional visibility, recognition, and brand awareness in the investment community (https://ibn.fm/gSIll).

Lomecel-B(TM) is an allogeneic medicinal signaling cell (“MSC”). MSCs appear to possess anti-inflammatory, pro-vascular, and pro-regenerative properties.

The study met its primary safety endpoint across all study groups based on statistical and medical assessments, with the safety data consistent with an established safety profile with no incidence of hypersensitivity, no cases of Alzheimer Related Imagine Abnormalities (“ARIA”), no clinically asymptomatic microhemorrhages, and no notable changes in laboratory evaluations and electrocardiogram (“ECG”) reported. Moreover, the study revealed statistically significant improvements in the secondary endpoint Composite Alzheimer’s Disease Score (“CADS”) for Lomecel-B(TM) and specific components of the CADS.

“These study results with Lomecel-B(TM) are encouraging,” commented Dr. Jeffrey Cummings, MD, Vice Chair of Research at UNLV’s Department of Brain Health. “The study met its primary safety endpoint and is supported by lack of deterioration in cognitive or atrophy signals. The efficacy observations are encouraging, and these results should be used as a foundation for further studies.”

We believe these results provide important validation of both the safety and therapeutic potential of Lomecel-B(TM) in the treatment of Alzheimer’s Disease, and provide a solid foundation for additional clinical trials in this and other indications,” said Wa’el Hashad, CEO of Longeveron.

Longeveron initiated the CLEAR MIND trial in January 2021 with the aim of obtaining safety and efficacy data following single and multiple infusions of two different dose levels of Lomecel-B(TM) compared to placebo. The study employed a double-blind, 4-arm, parallel design in which 48 patients with mild AD were randomized into the four arms at an allocation ratio of 1:1:1:1, meaning each treatment arm had 12 patients (https://ibn.fm/sBh8e).

In an October 5 webcast during which the company discussed the topline results, Dr. Nataliya Agafonova, Chief Medical Officer of Longeveron, clarified that a total of 49 patients had been treated in the study, 22 being male, with the rest female (https://ibn.fm/ra029). The study was conducted over 45 weeks, which included a 6-week screening period, 12-week treatment period, and 27-week follow-up period.

The study built on positive Phase 1 data reported in 2021 following the completion of the Phase 1 study, which met its primary safety endpoint. Positive secondary efficacy assessments supported the potential therapeutic benefit of Lomecel-B(TM), according to an April 2021 news release (https://ibn.fm/xt78n). Lomecel-B(TM) resulted in a slower decline in cognitive function in patients who received low dose Lomecel-B(TM) compared with placebo. Moreover, quality of life metrics appeared to improve with Longeveron’s Lomecel-B(TM) investigational product as compared to placebo. These results were published in a leading journal, Alzheimer’s and Dementia, the Journal of the Alzheimer’s Association, last year (https://ibn.fm/SLf5q).

Looking ahead, Longeveron plans to announce additional exploratory and biomarker data from the Phase 2a trial which may provide additional insights of the clinical effects of Lomecel-B(TM) in the study population, according to Mr. Hashad.

Investor Contact Mike Moyer LifeSci Advisors Tel: 617-308-4306 Email: mmoyer@lifesciadvisors.com

For more information, visit the company’s website at www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at http://ibn.fm/LGVN

Forward-Looking Statements

Certain statements in this press release that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, the anticipated use of proceeds from the offering, as well as statements about the ability of Longeveron’s clinical trials to demonstrate safety and efficacy of the company’s product candidates, and other positive results; the timing and focus of the company’s ongoing and future preclinical studies and clinical trials and the reporting of data from those studies and trials; the size of the market opportunity for the company’s product candidates, including its estimates of the number of patients who suffer from the diseases being targeted; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of the company’s product candidates; the company’s ability to obtain and maintain regulatory approval of its product candidates in the U.S., Japan and other jurisdictions; the company’s plans relating to the further development of its product candidates, including additional disease states or indications it may pursue; the company’s plans and ability to obtain or protect intellectual property rights, including extensions of existing patent terms where available and its ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and the company’s ability to attract and retain such personnel; the company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the company’s need to raise additional capital, and the difficulties it may face in obtaining access to capital, and the dilutive impact it may have on its investors; market and other conditions; the company’s financial performance and ability to continue as a going concern, and the period over which it estimates its existing cash and cash equivalents will be sufficient to fund its future operating expenses and capital expenditure requirements. Further information relating to factors that may impact the company’s results and forward-looking statements are disclosed in the company’s filings with the Securities and Exchange Commission, including Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023 and its Quarterly Report on Form 10-Q for the third quarter of 2023 filed with the SEC on November 9, 2023. The forward-looking statements contained in this press release are made as of the date of this press release, and the company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

• Sekur, a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management, is pushing its SekurMessenger amid SEC crackdowns on Wall Street
• The app provides end-to-end encryption, proprietary VirtualVaults, and HelixTech that ensure conversations are secure while also maintaining privacy
• It allows companies on Wall Street to meet the FINRA communication compliance requirements while giving them the overall peace of mind that comes with guaranteed security and encryption
• With this offering, Sekur looks to carve out a significant market share while also asserting itself as a leader in its segment

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0), a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management, is offering a secure, easy-to-use, and transparent messaging solution to Wall Street companies amid the U.S. Securities and Exchange Commission (“SEC”) crackdowns. SekurMessenger is an encrypted messaging service that offers full privacy for users, enabled by multiple layers of data protection that guarantee the security of communications (https://ibn.fm/1UsBM).

The SEC has levied over $2.5 billion in fines on Wall Street, the product of two years of investigations into the industry’s use of messaging apps. These investigations have seen major firms such as Wells Fargo, Bank of America, Goldman Sachs, and Morgan Stanley, fined for failing to maintain work-related communications records on their preferred messaging apps. With the institution tightening regulations on internal communication and enforcing them to comply with the Financial Industry Regulatory Authority (“FINRA”), Wall Street has been forced to explore alternatives that meet and exceed the stipulated thresholds.

SekurMessenger is currently available on both iOS and Android and on the web. Features include end-to-end encryption, proprietary VirtualVaults, and HelixTech that ensure conversations are secure while also providing a way to maintain privacy. In addition, any messages or files sent or received between users are stored in a secure cloud hosted on Swiss-based Sekur-owned servers with military-grade security, letting compliance archiving the messages, while users themselves can delete them from their devices, protecting the chats from hacker intrusion (https://ibn.fm/1yWje). Switching to this offering would allow Wall Street companies to meet the communication compliance requirements by FINRA while also giving them a significant head start and the overall peace of mind that comes with guaranteed security and encryption of internal communication.

The SEC’s unrelenting push and crackdown on Wall Street puts even more pressure on companies to comply, and Sekur is looking to take advantage of it. With this initial offering, the company looks to carve out a significant market share, even as it plans to roll out more enterprise-related features, such as a fully private network and mass employee onboarding platform later this year. In addition, the company is asserting itself as a leader in its segment, defining itself as an innovator and trendsetter in its space.

For more information, visit the company’s website at www.Sekur.com.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF

• SuperCom, a global leading provider of traditional and digital identity solutions, just announced its latest order from the Romanian government to the tune of $3.4 million
• SuperCom will help Romania’s Ministry of Interior to bolster its EM project, based on its PureSecurity Suite, covering domestic violence monitoring, GPS tracking of offenders, as well as home detection monitoring
• Deliveries are set to be met by the end of Q4 2023, and SuperCom’s management is optimistic that the order will boost the company’s overall value proposition and lead to many more orders down the line

SuperCom (NASDAQ: SPCB), a leading global provider of traditional and digital identity solutions offering advanced safety, identification, and security products and solutions to governments, recently announced its continued collaboration with the Romanian government. The latest order from the country’s Ministry of Interior is part of an ongoing $30 million project, bolstering the country’s National Electronic Monitoring (“EM”) Project (https://ibn.fm/VALGi).

The EM program is based on SuperCom’s PureSecurity Suite, covering domestic violence monitoring, GPS tracking of offenders, and home detection monitoring. This end-to-end suite offers a secure real-time software platform. Years of testing and on-ground application have proven its effectiveness, affirming SuperCom’s overall approach of designing the suite to meet the unique needs of correctional facilities and law enforcement agencies worldwide.

This new order, valued at $3.4 million, builds on two prior orders from the Romanian government, totaling approximately $15.1 million. According to Ordan Trabelsi, President and CEO of SuperCom, “The recent order, valued at $3.4 million, underscores the caliber of our technology and the unwavering trust our clients have in SuperCom.”

When Romania kicked off its EM project, it looked to cover up to 15,000 enrollees simultaneously across the country. This would also include a unique integration of multiple offenders tracking sub-programs, goals which SuperCom helps them achieve. This latest order further stamps the company’s position as a market leader, offering superior, unrivaled products and services in the EM space.

“This latest order reinforces our status as a global frontrunner in electronic monitoring solutions. At SuperCom, we are dedicated to not only achieving excellent outcomes but also building enduring relationships with governments across the globe,” noted Mr. Trabelsi.

Deliveries are set to be met by the end of the fourth quarter of the 2023 calendar year. SuperCom’s management is optimistic that this order will help boost the company’s overall value proposition, allow for market expansion, and, most importantly, facilitate growth in shareholder value. Having stamped its status as a global frontrunner, the company’s management is confident that this order will lead to many more.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• Lexaria, a global innovator in drug delivery platforms, has, since 2014, continuously worked on its patented DehydraTECH(TM) drug delivery technology
• The technology has demonstrated overall effectiveness in enhanced delivery of fat-soluble molecules through the human gastrointestinal system, as affirmed by clinical testing
• This overall effectiveness and push for its development has earned Lexaria 37 granted patents globally, with many patents pending
• The company is constantly enhancing its patent portfolio, since granted patents can support an increase in licensing revenue

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is eyeing growth in license revenue from its intellectual property (“IP”). Since 2014, the company has continuously worked on its flagship technology – the patented DehydraTECH(TM) drug delivery technology – which has demonstrated the improvement of speed of onset, brain absorption, and bioavailability (https://ibn.fm/KSkD1). It is being investigated in association with dementia treatment, nicotine replacement, hypertension, and heart disease treatment, among other applications (https://ibn.fm/ItdVS).

So far, Lexaria has received 37 granted patents globally, with many patents pending. The company is aggressively pushing its patent application process as it recognizes the viable commercial application of its flagship technology. In addition, the company understands that successfully granted patents can lead to an increase in shareholder value as a recognized growing market leader.

“Because of the applicability of DehydraTECH to many market sectors across the globe, we have taken the necessary steps to protect that intellectual property internationally,” notes the company’s 2022 Form 10-K annual report (https://ibn.fm/xxsuF).

Lexaria’s patent portfolio currently spreads across the US, Australia, Japan, Mexico, the European Union, Canada and India. Its strategic approach of filing for applications in lucrative markets is a move to maximize potential revenue for years to come, mainly since out-licensing is a significant revenue stream for the company. DehydraTECH applications have shown that it can be applied in the consumer-packaged goods industry and the drug and pharmaceutical sectors. It has demonstrated suitability in various consumer formats such as oral suspensions, capsules, pills and tablets, nutraceuticals, registered drugs, and topical applications (https://ibn.fm/ZP6LI).

This is all made possible by DehydraTECH’s overall effectiveness in delivering most fat-soluble molecules through the human gastrointestinal system, as demonstrated by its overall effectiveness in crossing the blood-brain barrier once within blood plasma. Test data, both in vitro, in vivo, and human clinical testing, has shown that DehydraTECH reduces the time required to enter the bloodstream. It has also shown an increase in absorption rate, as well as the improvement of the taste and smell of edible products.

“Our current patent portfolio includes patent family applications or grants pertaining to our method of improving bioavailability and taste, and the use of DehydraTECH as a delivery platform for a wide variety of APIs including, but not limited to fat-soluble vitamins; anti-viral drugs; phosphodiesterase inhibitors; human hormones; regulated cannabinoids; and nicotine and its analogs,” notes Lexaria’s most recent Form 10-Q quarterly report (https://ibn.fm/A8THJ).

In June 2023, Lexaria received its latest two granted patents in Canada, bringing the total in the country to five. This followed the staggered receipts of three patents in the country in less than a year, a milestone that recognizes and protects the company’s improved compositions and methods for transdermal and dermal delivery of cannabinoids such as tetrahydrocannabinol (“THC”) and CBD. As it continues to push for more approvals, the company is steadily propping itself up for even more success, stamping its position as a leader in its space. More importantly, it is echoing its commitment to creating shareholder value.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Turbo Energy in September 2023 announced its successful debut on the Nasdaq stock exchange
• The company operates as a subsidiary of Umbrella Solar Investment S.A.
• Turbo Energy’s total revenue for the year ended December 31, 2022, increased by 82% year-over-year to €31,148,676 (approximately $33,321,219)
• In October 2023, the company was awarded a software patent in Spain related to its flagship Sunbox product

Turbo Energy (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally.

Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic installation. The Sunbox is powered by AI and features a software system that monitors the generation, use and management of photovoltaic energy by analyzing large amounts of data related to energy generation, consumption, market prices and weather forecasts. This AI system optimizes battery usage, reducing electricity bills and providing peak-use reduction and uninterruptible power supply functions.

Turbo Energy currently sells its photovoltaic energy equipment primarily through distributors for residential consumers in Spain, but it possesses the expertise and international perspective to expand its product portfolio into industrial and commercial scale and markets, as well as advancing the internationalization process it has already started. The company plans to expand into the industrial photovoltaic sector with its new Sunbox, launched in 2023, in higher power and capacity variants. Its goal is to become a significant player in this sector and contribute to the growth of renewable energy solutions.

The company was incorporated in 2013 and is based in Valencia, Spain. It operates as a subsidiary of Umbrella Solar Investment S.A.

Products

Lithium-Ion Batteries

Turbo Energy is one of the leading companies that introduced lithium-ion batteries for photovoltaic energy storage in Spain. Primarily for the home energy storage market, the company’s batteries have capacities from 2.24 kWh to 5.1 kWh in 24 and 48 volts. In addition, its 48V / 5.1 kWh units are available in a dual battery system.

Inverters

The inverter converts the direct current produced by the photovoltaic panels into alternating current that can be used by household appliances. It also regulates battery charging and discharging based on energy needs and optimizes utilization of generated renewable energy. Turbo Energy currently offers multiple models that cover most household installations.

All-in-One Sunbox

This product incorporates inverters, batteries and the rest of the components necessary to operate and protect the photovoltaic installation. This saves installation cost and assembly and configuration time while preventing errors. Notably, the latest Sunbox models also offer an EV charging option.

Software System

In communication with the inverter, the company’s software monitors energy flows between the photovoltaic panels, household consumption, storage and an optional electric vehicle charging station. The software allows users to customize an automatic backup mode based on weather forecasts, or manually select which part of the battery will be reserved for possible power outages. It also allows the battery to be used in a peak shaving mode, which leverages AI to trigger battery power when grid energy is most expensive, effectively reducing the amount of high-cost power drawn from the grid.

Market Opportunity

According to a report by Fortune Business Insights, a global research and reporting firm, the solar energy storage battery market was estimated to be worth $3.33 billion in 2022 and is projected to reach a value of more than $20 billion by 2030, marking a CAGR of 24.2% over the forecast period.

These batteries are crucial components of renewable energy systems, allowing for the storage of excess electricity generated by solar panels, so it can be used during times of no or low sunlight. By storing energy and supplying it when needed, these batteries reduce reliance on the power grid and maximize self-consumption while helping users avoid peak electricity rates. They also contribute to the transition toward a cleaner and more sustainable energy future by enabling residential consumers and businesses to use solar power even when the sun is not shining.

Management Team

Enrique Selva Bellvís is the CEO and founder of the Umbrella Group. In addition, he serves as vice-president of the Valencian Association of Energy Sector Companies industry group. Before his career in the solar energy sector, he was the founder and CEO of Innova Ingenieros Consultores. He holds a degree in industrial engineering with a specialization in energy from the Polytechnic University of Valencia and completed the Management Development Programme at the IESE Business School.

Mariano Soria is the Chief Innovation Officer for the Umbrella Group and serves as General Manager of Turbo Energy. He was CEO of Punt Moble XXI S.L. and continues to serve on that company’s board. Before that, he was the General Manager of REJMAR S.A., a land development company. He received his degree in industrial engineering and industrial organization from the Polytechnic University of Valencia, and his MBA from the European University of Madrid.

Alejandro Moragues is CFO of Turbo Energy. Previously, he held the position of Senior Corporate Auditor for U.S. company Euronet Worldwide Inc. and was an external auditor for PricewaterhouseCoopers. He holds a bachelor’s degree in business administration and management from the Polytechnic University of Valencia.

Manuel Cercos is Chief Commercial Officer at Turbo Energy. Previously, he held positions at Técnicas Aplicadas en Baterías S.L., where he served as Sales Director and Sales Manager. Before that, he worked as a Sales Technician at DAISA.

For more information, visit the company’s website at www.Turbo-e.com.

NOTE TO INVESTORS: The latest news and updates relating to TURB are available in the company’s newsroom at https://ibn.fm/TURB

• SenesTech Inc., a visionary leader in fertility control to manage animal pest populations, has developed products that show success in limiting rat populations using unique non-lethal fertility reduction products
• Rodents are often associated with carrying diseases that can affect humans, and SenesTech’s non-lethal population-reducing technology targets this major problem in a uniquely humane, environmentally conscious, yet effective way
• The Arizona-based company has developed two primary products — its liquid ContraPest(R) brand, and the recently introduced Evolve(TM) Soft Bait formulation, soft bait being favored by rodent control professionals
• The company anticipates using their technology to develop similar pest-control products for other species in the near future

Close on the heels of introducing a new product expected to create exponential revenue growth for the company, pest animal control innovator SenesTech (NASDAQ: SNES) reported its Q3 financial status to investors Nov. 9, highlighting the company’s continued progress in a year that has seen a record sequential quarterly increase in its earnings.

An archived recording of the Q3 report can be found on SenesTech’s Investor Relations page, at https://ibn.fm/AeEie.

SenesTech’s commitment to sustainable, non-toxic rodent reduction, is reflected in the company’s drive to market a global pest solution that introduces fertility control as the ideal alternative to toxic poisons.

Its trademarked liquid ContraPest(R) bait and Evolve(TM) Soft Bait both target the rapid birth rate in rodent populations, which can result in 15,000 offspring for a single pair of breeding rats in a year’s time and half a billion descendants within three years, according to research cited by President & CEO Joel Fruendt during an October webcast also available on the company’s archived recording webpage.

ContraPest established the company’s reputation with a brand that has shown success in reducing rat populations and subsequently increasing the profitability of poultry enterprises on both the East and West Coasts. The pest control industry’s preference for non-liquid applications then led SenesTech to formulate a non-liquid soft bait solution in its new Evolve product.

“Evolve was developed to offer customers a soft bait product that has similar efficacy to ContraPest(R), but in a format that is easier to deploy and that they can use daily in their integrated pest management programs,” Fruendt stated in a Nov. 1 news release announcing that the company is now taking orders from commercial customers for the soft bait formulation (https://ibn.fm/guMGb).

“Evolve is also suited for use by consumers,” he added, “and we expect to announce partnerships with e-commerce providers and big box retailers by the end of the year.”

The company states that Evolve is highly palatable to rats, and can be placed virtually anywhere rats are found, ranging from outdoor parks and recreation facilities to medical facilities and residential locations.

Evolve currently is only formulated for rats, although the company expects to expand to other pest species in the near future. The product’s active ingredient is a compound derived from cottonseed oil administered in doses too low to affect other species’ fertility as long as the product isn’t consumed in substantial quantities over extended periods of time, but the company recommends using tamper-resistant bait stations to minimize potential non-target species exposure.

Evolve is designed for repeated application. Its non-lethal approach to rodent birth control anticipates a cumulative effect over time with a half-life of approximately three days after consumption, and the company states rats will regain their fertility within approximately six weeks after they stop consuming the bait.

With the advent of cooler weather in the Northern Hemisphere, rodent activity becomes more noticeable because of their efforts to find warm refuge. An estimated 21 million homes across the United States will be affected by rodent activity during the season, according to pest control corporation Orkin (https://ibn.fm/ASt6r).

SenesTech’s original liquid ContraPest brand has the benefit of targeting hard-to-get roof rodents, and is the only rat contraception product for both male and female rats registered with the Environmental Protection Agency (“EPA”).

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

• D-Wave and QuantumBasel announced a two-year extension to the strategic agreement between the companies to accelerate quantum and quantum-hybrid application development in Europe
• D-Wave will open a European office on the QuantumBasel campus to establish an onsite presence supporting the companies’ joint efforts to fast-track the region’s commercialization of quantum computing
• D-Wave’s European customers include QuantumBasel, BBVA, Koç Holding, Satispay, Poznan Superconducting and Network Center, and Cineca

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, and QuantumBasel, Switzerland’s quantum innovation hub, recently announced a two-year extension to the strategic agreement between the companies to accelerate quantum and quantum-hybrid application development in Europe.

As a part of the agreement, D-Wave will open a European office on the QuantumBasel campus to establish an onsite presence supporting the companies’ joint efforts to fast-track the region’s commercialization of quantum computing. D-Wave’s commitment to opening its European office reflects the growing regional customer interest in and usage of the company’s annealing quantum computing solutions, including the Advantage(TM) system.

Advantage is a fifth-generation annealing quantum system with 5,000+ qubits and 15-way connectivity. D-Wave has incorporated two decades of quantum technology development experience and over ten years of customer feedback to build the first and only quantum computer designed for business applications and operating today.

In addition to QuantumBasel, D-Wave’s European customers include BBVA, Koç Holding, Satispay, Poznan Superconducting and Network Center, and Cineca. Several other leading organizations also utilize D-Wave’s technology including Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO and Lockheed Martin.

“This extended partnership with D-Wave solidifies our shared dedication to quantum innovation in Switzerland and beyond,” said Damir Bogdan, CEO of QuantumBasel (https://ibn.fm/CA6hg). “Our collaboration is a promise to drive quantum advancements and progress towards broader commercial adoption.”

The initial strategic collaboration between D-Wave and QuantumBasel was signed in December 2022, which named D-Wave as the annealing quantum technology provider for QuantumBasel, giving the center’s tenants and customers access to the Advantage annealing quantum computer via D-Wave’s real-time Leap(TM) quantum cloud service. Since the agreement, uptownBasel and D-Wave have successfully led joint go-to-market initiatives and worked on numerous customer engagements.

Using the Leap quantum cloud service, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail, and transportation. With quantum computational processing power, D-Wave is helping businesses accelerate time-to-solution for their complex computing problems. The company shares real-world quantum applications at a business scale through its client success stories (https://ibn.fm/DgnCG).

“QuantumBasel and D-Wave share a vision of solving the world’s most complex problems for the betterment of industry and society. Today’s announcement reflects strong progress toward achieving that mission, as joint customers are quickly realizing the near-term advantage of D-Wave’s quantum technology,” said Dr. Alan Baratz, CEO of D-Wave. “Through our collaboration and now our European office presence, we anticipate accelerated momentum for quantum and quantum-hybrid applications moving into production and fueling operations.”

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward-Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. Forward-looking statements in this press release include, but are not limited to, statements regarding the opening of D-Wave’s European office, and the potential benefits of D-Wave’s European presence and the continued collaboration between D-Wave and QuantumBasel. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the availability of office space at QuantumBasel, general economic conditions and other risks; the company’s ability to expand its customer base and the customer adoption of its solutions; risks within D-Wave’s industry, including anticipated trends, growth rates, and challenges for companies engaged in the business of quantum computing and the markets in which they operate; the outcome of any legal proceedings that may be instituted against the company; risks related to the performance of the company’s business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and/or timing thereof; the performance of the company’s products; the effects of competition on its business; the risk that the company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that D-Wave may never achieve or sustain profitability; the risk that the company is unable to secure or protect its intellectual property; volatility in the price of the company’s securities; the risk that the company’s securities will not maintain the listing on the NYSE; and the numerous other factors set forth in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to the company on the date hereof. The company undertakes no duty to update this information unless required by law.

GolfLync, a leading social networking hub for golf lovers, is revolutionizing the online golfing world. Recently, influencers from various platforms have been flocking to GolfLync, bringing along their followers. This trend has led GolfLync to introduce an array of features aimed at enabling these influencers to broaden their reach and grow their brand. This integration not only enhances the visibility of influencers but also provides them with tools to manage and rotate posts across the feeds.

In an effort to bolster the credibility and authenticity of its influencer community, GolfLync has implemented a new verification process. Influencers can now apply for verification using a government-issued ID, earning a distinctive blue verification mark on their accounts. Incentive programs are being offered to select influencers to build their brands on the platform to earn a gold badge and top rewards in our program. Influencers can apply for influencer status in-app. For more information, please visit www.GolfLync.com/influencer-features.

This mark serves as a badge of authenticity, protecting the brand identity of influencers and instilling trust among their followers. Furthermore, GolfLync will be releasing a dedicated filter for staying updated on influencers, making it easier for members to discover and receive content from prominent figures in the golfing world. This dedicated filter not only elevates the visibility of influencers but also enriches the member experience by providing curated, high-quality golf content.

GolfLync is a game-changer for the platform and its users, and will also be introducing the integration of seamless content sharing between Instagram and Facebook. This feature enhances the golfing journey by enabling users to effortlessly share their golfing experiences and insights across their social networks. By doing so, it fosters a more interconnected and vibrant golfing community, where experiences and tips are freely exchanged, thus enriching the overall member experience.

GolfLync’s commitment to maintaining a genuine and safe online environment is further exemplified through enhanced reporting tools. Users now have the power to report spam and bots effectively, safeguarding the platform’s authenticity and ensuring a high-quality experience for all members. Additionally, the introduction of an in-app verification application process is a significant stride in enhancing trust and recognition within the GolfLync community. This feature allows users to apply for verified status, thereby elevating their profile within the golfing network.

These latest enhancements by GolfLync are more than just features; they represent a holistic approach to taking golf networking to unprecedented heights. By intertwining social media functionality with a dedicated golfing platform, GolfLync is setting a new standard in digital golf networking. Explore these exciting new features today and experience the evolution of golf social networking.

About GolfLync
GolfLync is the ultimate social media platform for golfers, connecting like-minded enthusiasts, fostering vibrant golfing communities, and redefining the golfing experience. With a user-friendly interface and advanced features, GolfLync brings golfers together and provides a space for golfers to connect, share, and celebrate their shared passion. Download the GolfLync app today and explore the world of golf like never before!

For more information about GolfLync and the groundbreaking initiatives that are transforming the golfing landscape, visit the company’s website at GolfLync and be part of a revolution in golfing camaraderie.

GolfLync APPs are available for free from both the Apple Store ‎GolfLync and Google Play GolfLync – Apps on Google Play.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

• Diamond Lake Minerals is multi-strategy operating company focused on building, acquiring and developing companies within a wide variety of industries
• DLMI’s strategy involves bridging generations of investors with accessible digital investment technology in sectors ranging from music and entertainment to real estate, healthcare and digital tokens
• Security token-centered ecosystems are gaining traction around the world, providing digital alternatives to traditional investments such as stocks or bonds — digital investments that may nonetheless deliver rights to assets that have real value
• DLMI is conscientious about the need to comply with SEC regulations and provide transparency to its shareholders, drawing on the decades of experience held in reserve by the company’s executive team

Earlier this year, one of South Korea’s biggest commercial banks — NongHyup — established a security token-centered ecosystem that has produced a consortium joined by other large banks in the country (https://ibn.fm/rsKhn). This month, brokerage firm Cathay Securities announced it had become the first financial investment company in Taiwan to gain authorization to launch that country’s first security token offering (“STO”) business, showing the continued growth of STOs globally (https://ibn.fm/cVZ1f).

Multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is establishing its own profound take on a vertically integrated ecosystem for digital assets and SEC-registered security tokens in North America.

Leaving behind its long-standing efforts as a mineral mining holding enterprise, DLMI is drawing on the strengths and vision of an experienced executive team to build an engine that powers digital wealth across generations with diverse expectations and approaches to technology.

STOs first appeared around 2019 and have been becoming increasingly popular across a number of blockchain ecosystems as digital alternatives to traditional investments such as stocks or bonds, that may nonetheless deliver rights to assets that have real value such as share ownership in real estate, investment funds and artwork.

Key to DLMI’s mission is its adherence to U.S. Securities and Exchange Commission (“SEC”) regulations and its emphasis on transparency, liquidity and security. The company is industry-agnostic, working to start, acquire and build enterprises as a parent company in sectors ranging from music and entertainment to real estate, healthcare and digital tokens.

Underscoring that purpose, DLMI sees a need to also provide the public with an education about digital assets at what appears to be a new frontier for financial markets. Importantly for the public, investing in DLMI stock is a good way of getting into digital assets, without actually having to figure out how to buy things like crypto, making DLMI stock a simple all-encompassing way to move comfortably into this growing market.

“By enabling digital assets to be traded via protocols, tokenization promises immediate settlement and lower transaction costs,” Benzinga stated in a Nov. 9 news analysis of the company’s operation (https://ibn.fm/KQxsu).

“What we’re doing is bringing back value to our shareholders in the form of highly coveted stock, something that will resemble, as we continue to perform and work, … a Berkshire Hathaway”, CEO Brian J. Esposito said during a recent interview with Benzinga Partner Studio (https://ibn.fm/ItacN). “What we want to do is give power back to investors to understand what they’re holding.”

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

In addition, for information on the company’s security token SEC regulated exchange partner INX, and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI